ShilpaKodatiMD
Ophthalmology • Ann Arbor, MIRetinal Disease, Uveitis
Vitreoretinal Surgeon and Uveitis specialist
Dr. Kodati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Wall St
Ann Arbor, MI 48105Phone+1 734-764-4190
Summary
- Dr. Shilpa Kodati is an ophthalmologist in Bethesda, MD. She specializes in vitreoretinal surgery and uveitis and is experienced in uveitis, retina surgery, immunology, vitreoretinal disease, and retinal imaging.
Education & Training
Baylor College of MedicineFellowship, Surgical Retina and Vitreous, 2017 - 2019
National Institutes of Health Clinical CenterFellowship, Ocular Immunology/Uveitis, 2016 - 2017
UPMC Medical EducationResidency, Ophthalmology, 2013 - 2016
MetroWest Medical CenterInternship, Transitional Year, 2012 - 2013
Imperial College London School of MedicineClass of 2008
Certifications & Licensure
DC State Medical License 2020 - 2026
TX State Medical License 2017 - 2026
MI State Medical License 2022 - 2025
PA State Medical License 2013 - 2024- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Intraocular Immune Response in Human Uveitis: Time to Look Beyond Animal Models.Soumyava Basu, Lynn Hassman, Shilpa Kodati, Colin J Chu
American Journal of Ophthalmology. 2024-10-01 - Bilateral Exudative Retinal Detachments and Panuveitis in a Patient with Multiple Myeloma.Nam V Nguyen, Eleni K Konstantinou, Noha Sherif, Matias Soifer, Marena Patronas
Ocular Immunology and Inflammation. 2024-09-01 - EXTENSIVE SUBRETINAL FIBROSIS ASSOCIATED WITH PSEUDOXANTHOMA ELASTICUM.Enny Oyeniran, Henry Wiley, Sunil Bellur, H Nida Sen, Carlos R Ferreira
Retinal Cases & Brief Reports. 2024-07-01
Press Mentions
First U.S. Patient Receives Autologous Stem Cell Therapy to Treat Dry AMDSeptember 2nd, 2022- First US Patient Gets Autologous Stem Cell Therapy to Treat Dry AMDSeptember 1st, 2022
- ARVO Foundation Announces 2021 Mallinckrodt Uveitis Research Fellowship RecipientJanuary 21st, 2021
Professional Memberships
- Member
- Member
- American Uveitis SocietyMember
- The Association for Research in Vision and OphthalmologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
